Adagrasib (MRTX849)

adagrasib · Mirati Therapeutics

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Adagrasib (MRTX849), covering 2025-08-26 to 2025-08-26. Get the full timeline:

Most recent: Clinical Trial Update: Expanded Access of Adagrasib (MRTX849) in Patients With Advanced Solid Tumors Who Have a KRAS G12C Mutation